Status:
COMPLETED
A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema
Lead Sponsor:
Allergan
Conditions:
Macular Edema
Eligibility:
All Genders
Brief Summary
This retrospective chart review study will describe the history of patients with retinal disease with macular edema to whom OZURDEX® (dexamethasone intravitreal implant) is administered, and assess tr...
Eligibility Criteria
Inclusion
- Retinal disease involving macular edema
- Received at least one OZURDEX® injection
Exclusion
- None
Key Trial Info
Start Date :
September 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2013
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT01805323
Start Date
September 1 2012
End Date
April 15 2013
Last Update
April 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Québec, Quebec, Canada